Cargando…

Case of ST-Elevation Myocardial Infarction in a 32-Year-Old Male Receiving Bleomycin, Etoposide, and Cisplatin Chemotherapy for Embryonal Carcinoma

Myocardial infarction in young individuals has unique risk factors compared to the older population. Along with usual risk factors, one should explore causes such as recreational drug use, medication-induced myocardial infarction, and spontaneous coronary artery dissection. Here, we present the case...

Descripción completa

Detalles Bibliográficos
Autores principales: Bassil, Emmanuel, Singh, Harjinder, Ahmed, Omair, Parikh, Shamik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327993/
https://www.ncbi.nlm.nih.gov/pubmed/37425586
http://dx.doi.org/10.7759/cureus.40089
_version_ 1785069704649375744
author Bassil, Emmanuel
Singh, Harjinder
Ahmed, Omair
Parikh, Shamik
author_facet Bassil, Emmanuel
Singh, Harjinder
Ahmed, Omair
Parikh, Shamik
author_sort Bassil, Emmanuel
collection PubMed
description Myocardial infarction in young individuals has unique risk factors compared to the older population. Along with usual risk factors, one should explore causes such as recreational drug use, medication-induced myocardial infarction, and spontaneous coronary artery dissection. Here, we present the case of a 32-year-old male who presented with chest pain and was found to have complete thrombotic occlusion of the right coronary artery. He recently started receiving chemotherapy with bleomycin, etoposide, and cisplatin (PEB). In the absence of other risk factors and previous reports of similar cardiotoxicity with bleomycin, the patient was deemed to have an adverse effect from the chemotherapy regimen.
format Online
Article
Text
id pubmed-10327993
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-103279932023-07-08 Case of ST-Elevation Myocardial Infarction in a 32-Year-Old Male Receiving Bleomycin, Etoposide, and Cisplatin Chemotherapy for Embryonal Carcinoma Bassil, Emmanuel Singh, Harjinder Ahmed, Omair Parikh, Shamik Cureus Cardiology Myocardial infarction in young individuals has unique risk factors compared to the older population. Along with usual risk factors, one should explore causes such as recreational drug use, medication-induced myocardial infarction, and spontaneous coronary artery dissection. Here, we present the case of a 32-year-old male who presented with chest pain and was found to have complete thrombotic occlusion of the right coronary artery. He recently started receiving chemotherapy with bleomycin, etoposide, and cisplatin (PEB). In the absence of other risk factors and previous reports of similar cardiotoxicity with bleomycin, the patient was deemed to have an adverse effect from the chemotherapy regimen. Cureus 2023-06-07 /pmc/articles/PMC10327993/ /pubmed/37425586 http://dx.doi.org/10.7759/cureus.40089 Text en Copyright © 2023, Bassil et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Bassil, Emmanuel
Singh, Harjinder
Ahmed, Omair
Parikh, Shamik
Case of ST-Elevation Myocardial Infarction in a 32-Year-Old Male Receiving Bleomycin, Etoposide, and Cisplatin Chemotherapy for Embryonal Carcinoma
title Case of ST-Elevation Myocardial Infarction in a 32-Year-Old Male Receiving Bleomycin, Etoposide, and Cisplatin Chemotherapy for Embryonal Carcinoma
title_full Case of ST-Elevation Myocardial Infarction in a 32-Year-Old Male Receiving Bleomycin, Etoposide, and Cisplatin Chemotherapy for Embryonal Carcinoma
title_fullStr Case of ST-Elevation Myocardial Infarction in a 32-Year-Old Male Receiving Bleomycin, Etoposide, and Cisplatin Chemotherapy for Embryonal Carcinoma
title_full_unstemmed Case of ST-Elevation Myocardial Infarction in a 32-Year-Old Male Receiving Bleomycin, Etoposide, and Cisplatin Chemotherapy for Embryonal Carcinoma
title_short Case of ST-Elevation Myocardial Infarction in a 32-Year-Old Male Receiving Bleomycin, Etoposide, and Cisplatin Chemotherapy for Embryonal Carcinoma
title_sort case of st-elevation myocardial infarction in a 32-year-old male receiving bleomycin, etoposide, and cisplatin chemotherapy for embryonal carcinoma
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327993/
https://www.ncbi.nlm.nih.gov/pubmed/37425586
http://dx.doi.org/10.7759/cureus.40089
work_keys_str_mv AT bassilemmanuel caseofstelevationmyocardialinfarctionina32yearoldmalereceivingbleomycinetoposideandcisplatinchemotherapyforembryonalcarcinoma
AT singhharjinder caseofstelevationmyocardialinfarctionina32yearoldmalereceivingbleomycinetoposideandcisplatinchemotherapyforembryonalcarcinoma
AT ahmedomair caseofstelevationmyocardialinfarctionina32yearoldmalereceivingbleomycinetoposideandcisplatinchemotherapyforembryonalcarcinoma
AT parikhshamik caseofstelevationmyocardialinfarctionina32yearoldmalereceivingbleomycinetoposideandcisplatinchemotherapyforembryonalcarcinoma